Skip to content
Back to Guavy Wire
Stocks

Indian American Cardiovascular Geneticist Wins 2026 Population Research Prize

Instruments
AMGN
Share

Indian American cardiovascular genetics innovator Dr. Pradeep Natarajan has been named as the winner of the 2026 Population Research Prize by the American Heart Association (AHA).

The award will be presented to Dr. Natarajan on November 8th during the Presidential Session at the AHA's annual Scientific Sessions in Chicago, which takes place from November 6-9.

Dr. Natarajan is an internationally recognized expert in using human genetics and large population studies to transform our understanding and prevention of cardiovascular disease. His research has uncovered genetic mechanisms in lipid disorders, coronary artery disease, and clonal hematopoiesis, while advancing polygenic risk scores and precision medicine approaches.

Dr. Natarajan's work has also accelerated the development of novel therapeutic targets for cardiovascular disease. He is currently the vice president of global research at Amgen, where he oversees human genetics and the cardiometabolic therapeutic area.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc